Could Inhibiting the DNA Damage Repair Checkpoint Rescue Immune-Checkpoint-Inhibitor-Resistant Endometrial Cancer?

Endometrial cancer (EC) is increasingly undermining female health worldwide, with poor survival rates for advanced or recurrent/metastatic diseases. The application of immune checkpoint inhibitors (ICIs) has opened a window of opportunity for patients with first-line therapy failure. However, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yinuo, Wang, Xiangyu, Hou, Xin, Ma, Xiangyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144486/
https://www.ncbi.nlm.nih.gov/pubmed/37109350
http://dx.doi.org/10.3390/jcm12083014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144486/
https://www.ncbi.nlm.nih.gov/pubmed/37109350
http://dx.doi.org/10.3390/jcm12083014

Ejemplares similares